EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY 4.0

Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review

Giustino Varrassi iD, Antonella Paladini iD, Y Van Tran, Van Phong Pham iD, Ameen A Al Alwany, Giacomo Farì iD, Annalisa Caruso, Marco Mercieri iD, Joseph V Pergolizzi, Alan D Kaye iD, Frank Breve, Alberto Corriero iD und 2 weitere

Cancers · 14.01.2026 · 18 (2) · 259

DOI: 10.3390/cancers18020259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.01.2026. Verfasst von Giustino Varrassi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Paolo Procacci, 00193 Roma, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cancer pain affects 55–95% of patients with advanced malignancy, representing a complex syndrome involving nociceptive, neuropathic and nociplastic mechanisms. Despite therapeutic advances, two-thirds of patients with metastatic cancer experience inadequate pain control. This scoping review synthesizes recent advances in cancer pain pathophysiology and management, focusing on molecular and cellular mechanisms, emerging pharmacological, interventional and technological therapies and key evidence gaps to inform future precision-based pain management strategies.

Methods

Following PRISMA-ScR methodology, we searched PubMed, Embase, Scopus, and Web of Science for studies published between January 2022 and September 2025. After screening 3412 records, 278 studies were included and analyzed across different domains: biological mechanisms, pharmacological management, interventional and neuromodulatory approaches, radiotherapy developments, and digital health innovations.

Results

Recent mechanistic research reveals cancer pain arises from tumor–neuron–immune crosstalk, with malignant cells secreting neurotrophic factors that promote axonal sprouting and nociceptor sensitization. Genetic polymorphisms and epigenetic modifications contribute to inter-individual pain variability. Management strategies are evolving toward multimodal precision medicine: NSAIDs and opioids remain foundational, complemented by adjuvant agents and interventional procedures including nerve blocks, intrathecal delivery, and neuromodulation (spinal cord and dorsal root ganglion stimulation). Stereotactic body radiotherapy demonstrates superior analgesic durability versus conventional approaches. Digital health innovations, such as mobile applications, remote monitoring, wearables, and AI-enabled predictive models, enable continuous assessment and personalized treatment optimization.

Conclusions

Cancer pain management is transitioning toward mechanism-based precision medicine integrating biological insights, advanced interventional techniques, and digital technologies. However, implementation challenges persist, including limited randomized trials for interventional approaches, the incomplete external validation of AI tools, and digital health equity concerns. Future research must prioritize prospective controlled studies and equitable integration into routine care.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecancer painneuromodulationpain managementprecision medicinetumor–neuron interactions

Autor:innen und Institutionen

  • Fondazione Paolo Procacci, 00193 Roma, Italy.
  • College of Medicine, University of Baghdad, Baghdad 10071, Iraq.
  • Department of Medicina Clinica, Sanità Pubblica, Scienze della Vita e dell'Ambiente (MESVA), University of L'Aquila, 67100 L'Aquila, Italy.
  • Department of Anesthesiology and Pain Medicine, Binh Dan Hospital, Ho Chi Minh City 70000, Vietnam.
  • Department of Experimental Medicine (Di.Me.S.), University of Salento, 73100 Lecce, Italy.
  • Department of Surgery, Azienda Socio-Sanitaria Territoriale (ASST) Lodi, 26900 Lodi, Italy.

ORCID-Profile: Giustino Varrassi, Antonella Paladini, Van Phong Pham, Giacomo Farì, Marco Mercieri, Alan D Kaye, Alberto Corriero, Matteo Luigi Giuseppe Leoni

Zitieren

APA

Varrassi, G., Paladini, A., Tran, Y. V., Pham, V. P., Al Alwany, A. A., Farì, G., Caruso, A., Mercieri, M., Pergolizzi, J. V., Kaye, A. D., Breve, F., Corriero, A., Gharibo, C., & Leoni, M. L. G. (2026). Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review. Cancers, 18(2), 259. https://doi.org/10.3390/cancers18020259

Vancouver

Varrassi G, Paladini A, Tran YV, Pham VP, Al Alwany AA, Farì G, et al. Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review. Cancers. 2026;18(2):259. doi:10.3390/cancers18020259

BibTeX
@article{Varrassi2026,
  author = {Varrassi, Giustino and Paladini, Antonella and Tran, Y Van and Pham, Van Phong and Al Alwany, Ameen A and Farì, Giacomo and Caruso, Annalisa and Mercieri, Marco and Pergolizzi, Joseph V and Kaye, Alan D and Breve, Frank and Corriero, Alberto and Gharibo, Christopher and Leoni, Matteo Luigi Giuseppe},
  title = {Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {259},
  doi = {10.3390/cancers18020259}
}
Kostenlos starten →